SEC Form D private-offering filing

BioLattice Ophthalmics, Inc,

Name: BioLattice Ophthalmics, Inc, - new SEC Form D private-offering filing, Philadelphia, PA
Published: 2026-03-30

A new SEC Form D private-offering notice from Philadelphia, PA, a $2,500,000 filer-stated offering target in Biotech. The source filing is one click away.

BioLattice Ophthalmics, Inc, site↗ Verified via SEC Form D

Develops CorneaClear, an engineered synthetic cornea alternative to donor tissue for corneal transplant patients.

Filed 2026-03-30Filed to raise $2,500,000First money in 2026-03-06Raised so far $575,000HQ (as filed) Philadelphia, PASector Biotech ✓Stage (inferred) SeedCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified biolatticetech.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.